Vanda Pharmaceuticals Inc. (FRA:VM4)
7.15
+0.35 (5.15%)
Last updated: Jan 8, 2026, 8:11 AM CET
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 368 employees as of December 31, 2024. The number of employees increased by 165 or 81.28% compared to the previous year.
Employees
368
Change (1Y)
165
Growth (1Y)
81.28%
Revenue / Employee
€491,170
Profits / Employee
€195,008
Market Cap
372.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 368 | 165 | 81.28% |
| Dec 31, 2023 | 203 | -87 | -30.00% |
| Dec 31, 2022 | 290 | 12 | 4.32% |
| Dec 31, 2021 | 278 | -14 | -4.79% |
| Dec 31, 2020 | 292 | 8 | 2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Vanda Pharmaceuticals News
- 5 days ago - FDA Approves Vanda Pharma Motion Sickness Drug, Fuels Upside - Benzinga
- 9 days ago - Vanda Pharmaceuticals: SG&A Takes Off, TAM Doesn't (Rating Downgrade) - Seeking Alpha
- 10 days ago - Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus - Seeking Alpha
- 11 days ago - What's Going On With Vanda Pharmaceuticals Stock Wednesday? - Benzinga
- 11 days ago - Vanda Pharmaceuticals Stock Surges 29% After FDA Clears Motion Sickness Drug - Nasdaq
- 11 days ago - Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
- 11 days ago - Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval - Barrons
- 11 days ago - Vanda Pharmaceuticals (VNDA) Surges 21% on FDA Approval of Motion Sickness Drug - GuruFocus